AI: DeepSeek (deepseek-chat)

Q: {
  "guidelineId": "carbetocin-to-prevent-pph-at-cs-uhs-cg-0009-2023-pdf",
  "fieldsProcessed": [
    "humanFriendlyName",
    "organisation",
    "yearProduced",
    "summary"
  ],
  "enhancedFields": 4,
  "contentLength": 1976
}

A: {
  "success": true,
  "enhancedFields": [
    {
      "field": "humanFriendlyName",
      "oldValue": null,
      "newValue": "Guideline for Carbetocin Use to Prevent Postpartum Hemorrhage in Cesarean Birth",
      "action": "added"
    },
    {
      "field": "organisation",
      "oldValue": null,
      "newValue": "RCOG",
      "action": "added"
    },
    {
      "field": "yearProduced",
      "oldValue": null,
      "newValue": "The text does not contain a publication year",
      "action": "added"
    },
    {
      "field": "summary",
      "oldValue": null,
      "newValue": "**Summary of Carbetocin Guideline for Postpartum Haemorrhage Prevention in Caesarean Birth** **Purpose**: Carbetocin is recommended to prevent postpartum haemorrhage during caesarean birth, replacing oxytocin (not used alongside it). **Administration**: - Give **100 mcg over 1 minute** after babyâ€™s birth and cord clamping. - Avoid pre-birth administration. - Consider dose reduction for low-risk elective cases; never exceed 100 mcg. **Roles**: - **Anaesthetist**: Prepares, administers, and documents. - **Obstetrician**: Manages 3rd stage, monitors uterine tone. - **Midwife**: Monitors tone/lochia, escalates concerns. - **Theatre team**: Maintains stock. **Contraindications**: Pregnancy before birth, hypersensitivity, severe cardiovascular disease, severe pre-eclampsia/eclampsia. **Cautions**: Cardiovascular disease (avoid if severe), hypotension, hyponatraemia, pre-eclampsia, general anaesthesia. **Adverse Effects**: Headache, nausea, hypotension, flushing, dyspnea, pruritis. **Monitoring**: Guideline compliance and incident reviews. **References**: BNF, SPC Carbetocin, NHS Injectable Medicines Guide",
      "action": "added"
    }
  ]
}